Last Updated on June 5, 2021 by The Health Master
Global pharma major, Lupin Limited, announced the launch of the authorized generic version of Brovana (arformoterol tartrate) inhalation solution 15 mcg/2 mL, unit-dose vials, of Sunovion Pharmaceuticals Inc.
Arformoterol tartrate inhalation solution 15 mcg/2 mL, is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is for use by nebulization only.
ICMR approved Self-test kit for C-19 launched
Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India
Glenmark launches drug for the treatment of seizures
Celon launches an emulsion-based drug to treat Black Fungus
JB Chemicals launches medicated Nicotine lozenges: Quit smoking
Merck launches synthetic cholesterol product
ICMR approved Self-test kit for C-19 launched
Serum Institute seeks DCGI’s nod to manufacture Sputnik V vaccine
Black fungus drug: Black marketing Racket busted
Zydus Cadila gets tentative USFDA nod for Osimertinib Tablets
Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India
USFDA accepts application from Lupin for Pegfilgrastim Biosimilar
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
